ClinicalTrials.Veeva

Menu

Efficacy and Safety of Narrow Focus (F1) Versus Wide Focus (F3) of Shock Wave Lithotripsy (SWL) for Renal Calculi

B

Benha University

Status

Enrolling

Conditions

Treatment Side Effects
Renal Stone

Treatments

Procedure: Shock Wave Lithotripsy (SWL)

Study type

Interventional

Funder types

Other

Identifiers

NCT04759599
MD 1-11-2020

Details and patient eligibility

About

This study aims to compare the narrow focus (F1) versus the wide focus (F3) in terms of the efficacy of Shock Wave Lithotripsy (SWL) in the management of renal calculi 1-2 cm and their injurious effect on the kidney.

Full description

Recently, some Shock Wave Lithotripsy (SWL) devices have been announced in the market with a different focus points. One early experimental study found that stone disintegration is better with small focusing points than larger focusing points. Nevertheless, these findings, in terms of the efficacy of stone disintegration, need to be validated in-vivo. Furthermore, the effect of focal size on renal injury during SWL need to be studied as well. Therefore, the objectives of this study are to compare the effect of using the narrow focus of 2mm (F1) versus the wide focus of 8 mm (F3) on the Stone Free Rate (SFR) following SWL for renal stones 1-2cm and estimating renal injury effect of F1 vs. F3 by urinary renal injury markers such as neutrophil gelatinase-associated lipocalin (NGAL) for assessment of proximal and distal renal tubules injury & Kidney Injury Molecule-1 (KIM-1) for assessment of proximal renal tubules injury).

The SWL device:

Lithotripter type: Piezo Lith3000 plus ( from Richard Wolf, Germany.

Enrollment

140 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Adult patients (>18years old) with 1-2 cm single renal stone.
  2. Normal functioning kidney.

Exclusion criteria

  1. Pregnancy.
  2. Bleeding diatheses.
  3. Radiolucent stones.
  4. Radio-opaque stones with Hounsfield Unit (HU) > 1200
  5. Patients with a pacemaker.
  6. Active Urinary Tract Infection (UTI).
  7. Severe skeletal malformations.
  8. Morbid obesity with Body Mass Index (BMI) ≥40 kg/m2.
  9. Renal artery aneurysm at the same site of the stone.
  10. Anatomical obstruction distal to the stone.
  11. Patients with renal impairment with serum creatinine > 1.2 mg/dL.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

140 participants in 2 patient groups

Group 1
Active Comparator group
Description:
Group 1 will undergo Shock Wave Lithotripsy (SWL) with focal size 2mm (F1), and 3000 shocks
Treatment:
Procedure: Shock Wave Lithotripsy (SWL)
Group 2
Active Comparator group
Description:
Group 2 will undergo Shock Wave Lithotripsy (SWL) with focal size 8mm (F3), and 3000 shocks
Treatment:
Procedure: Shock Wave Lithotripsy (SWL)

Trial contacts and locations

1

Loading...

Central trial contact

Yasser Noureldin, MD, PhD; Ezzat Elnahife, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems